BPC-157 and CJC-1295

Mentioned together

Named together in the same review articles, but never tested together. We say that plainly here, and show why researchers list them side by side.

How the two mechanisms relate

Neutral. BPC-157, studied in tissue-injury models, and CJC-1295, a GHRH analogue, are named together in research reviews but act on unrelated pathways, with no combined data recorded here.

This part is our reading of the mechanism. The grade above is what the published record shows.

The compounds

BPC-157

A pentadecapeptide studied mostly in animal models of tissue injury. Human evidence is small and uncontrolled, and no regulator has approved it.

Full profile, dosing and safety →

CJC-1295

A long-acting GHRH analogue studied for growth-hormone release. Two early human trials measured hormone levels; no human study here reports a functional outcome.

Full profile, dosing and safety →

Check these in the interaction tool →